OKYO Pharma Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +2,624.4% | +13,490.6% | -98.4% | +51,822.2% | +11.2% | -100.0% | +260,942.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -83.0% | -32.7% | +362.2% | +293.7% | +30.1% | -72.7% | -19.7% | |
| – | – | – | – | – | – | -1.4% | -62.2% | -39.8% | -65.4% | +57.9% | – | – | – | +454.3% | – | – | – | – | |
| – | -577.0% | – | – | +217.8% | -13.7% | +2.2% | -63.3% | -37.3% | -66.9% | +171.4% | +360.4% | -66.7% | +119.6% | +87.2% | +1.9% | +30.1% | -12.8% | -74.8% | |
| – | – | +89.5% | -106.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +52.9% | -99.6% | +8,700.0% | -85.2% | +371.9% | -93.3% | +182.0% | -26.4% | -58.8% | -100.0% | – | – | -2.9% | -100.0% | – | +989.4% | -16.1% | -46.4% | |
| – | – | -11.6% | -112.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +1,875.9% | -102.7% | – | – | +20,704,900.0% | +163,162.0% | -102.8% | – | – | -20,722,991.6% | – | – | – | – | – | -14,660.0% | – | |
| – | – | -11.6% | -112.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +124.8% | -105.0% | – | – | – | – | -145.4% | – | – | -117.3% | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.